TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia · Delayed Price · Currency is MYR 0.4750
0.00 (0.00%)
At close: Aug 10, 2026
TMC Life Sciences Berhad Financials Overview
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 387.04 | 345.63 | 346.42 | 311.56 | 243.77 | 201.02 |
Revenue Growth | 18.58% | -0.23% | 11.19% | 27.81% | 21.27% | 9.20% |
Gross Profit Gross Profit Growth | 130.37 | 109.67 | 138.02 | 126.06 | 87.88 | 69.5 |
Operating Income Operating Income Growth | 26.85 | 12.21 | 57.36 | 47.05 | 32.09 | 25.84 |
Net Income Net Income Growth | 15.16 | 3.61 | 40.65 | 39.26 | 41.39 | 20.25 |
Earnings Per Share EPS Growth | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS Growth | 586.66% | -91.13% | 3.71% | -5.31% | 104.85% | 27.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 118.12 | 111.64 | 191.13 | 168.69 | 143.14 | 141.16 |
Total Debt Total Debt Growth | 156.15 | 182.97 | 205.23 | 219.06 | 210.44 | 174.6 |
Net Cash (Debt) Net Cash Growth | -38.04 | -71.33 | -14.1 | -50.37 | -67.3 | -33.45 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.02 | -0.04 | -0.01 | -0.03 | -0.04 | -0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 60.39 | 22.51 | 74.76 | 54.57 | 35.65 | 22.45 |
Capital Expenditures CapEx Growth | -20.98 | -40.71 | -25.35 | -31.96 | -67.69 | -102.63 |
Free Cash Flow Free Cash Flow Growth | 39.42 | -18.2 | 49.41 | 22.61 | -32.04 | -80.18 |
Free Cash Flow Growth | - | - | 118.56% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 33.68% | 31.73% | 39.84% | 40.46% | 36.05% | 34.57% |
Operating Margin | 6.94% | 3.53% | 16.56% | 15.10% | 13.16% | 12.85% |
Pretax Margin | 5.61% | 2.05% | 15.19% | 13.12% | 13.20% | 13.77% |
Profit Margin | 3.92% | 1.04% | 11.73% | 12.60% | 16.98% | 10.08% |
FCF Margin | 10.18% | -5.27% | 14.26% | 7.26% | -13.15% | -39.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.002 | 0.002 | 0.005 | 0.004 | 0.003 | 0.002 |
Dividend Per Share Growth | -91.61% | -61.96% | 16.65% | 51.97% | 24.74% | 9.98% |
Dividend Yield | 0.39% | 0.43% | 0.78% | 0.74% | 0.58% | 0.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 54.60 | 207.71 | 28.28 | 26.62 | 21.46 | 53.75 |
Forward PE | - | 70.00 | 70.00 | 70.00 | 70.00 | 70.00 |
P/FCF Ratio | 20.99 | - | 23.27 | 46.23 | - | - |
PS Ratio | 2.14 | 2.17 | 3.32 | 3.36 | 3.64 | 5.42 |